XML 45 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock and Incentive Compensation Plans (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Black-Scholes Option Pricing Model
The table below includes the weighted-average assumptions used to calculate the grant date fair value of the ESPP rights for the periods indicated using the Black-Scholes option pricing model:
Three Months Ended March 31,
20242023
Expected term (in years)1.001.00
Dividend yield$2.08 $1.52 
Risk-free interest rate4.94 %2.00 %
Expected volatility31.12 32.56 
Schedule of ESPP Shares Purchased
The ESPP shares purchased are as follows for the dates indicated:
Three Months Ended March 31,
20242023
ESPP shares purchased— — 
Shares available for issuance under the ESPP927,698 973,911 
Schedule of Share-Based Compensation Cost Charged to Income
Share-based compensation cost charged to income for the years ended March 31, 2024 and 2023, is presented below. There was no stock option expense for any of the periods shown.
Three Months Ended March 31,
(Dollars in thousands)20242023
RSA & RSU$1,058 $1,022 
PSU915 293 
ESPP106 76 
Total stock compensation expense$2,079 $1,391 
Related tax benefits recognized in net income$437 $292 
Schedule of Time-Vested Award Activity
The following table summarizes the Company’s award activity:
Three Months Ended March 31,
20242023
SharesWeighted Average Grant-Date Fair ValueSharesWeighted Average Grant-Date Fair Value
Nonvested RSAs, January 1,17,629 $29.33 27,391 $35.27 
Vested RSAs— — (12,840)37.39 
Nonvested RSAs, March 31,
17,629 29.33 14,551 33.59 
Nonvested RSUs, January 1,318,168 $37.69 270,390 $39.63 
Granted RSUs8,761 30.43 65,842 40.69 
Vested RSUs(28,088)41.77 (12,005)44.77 
Forfeited RSUs— — (1,357)41.41 
Nonvested RSUs, March 31,
298,841 37.09 322,870 39.65 
Nonvested PSUs, January 1,197,842 $28.33 157,367 $29.06 
Granted PSUs— — 43,591 37.91 
Forfeited PSUs— — (1,592)37.91 
Nonvested PSUs, March 31,
197,842 31.74 199,366 30.50 
Schedule of Stock Option Activity
The table below summarizes the status of the Company’s stock options and changes during the three months ended March 31, 2024 and 2023.
(Dollars in thousands, except per share amounts)Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
Three Months Ended March 31, 2024
Outstanding at January 1, 2024353,473 $31.49 4.46$1,670 
Exercised(7,941)16.66 — 130 
Expired(2,151)37.18 — — 
Outstanding and exercisable at March 31, 2024
343,381 31.79 4.04771 
Three Months Ended March 31, 2023
Outstanding at January 1, 2023504,437 $29.46 5.13$3,736 
Exercised(27,282)15.62 — 587 
Expired(331)37.76 — — 
Outstanding and exercisable at March 31, 2023
476,824 30.24 5.001,728